Loading clinical trials...
Loading clinical trials...
This is a randomized, rt-PA controlled, open-label phase 3 clinical study to evaluate the efficacy and safety of recombinant human urokinase(rhPro-UK) versus rt-PA thrombolysis for patients with acute...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tasly Biopharmaceuticals Co., Ltd.
NCT07527013 · Endovascular Therapy, Acute Ischaemic Stroke, and more
NCT07321275 · Acute Ischaemic Stroke, Stroke-associated Pneumonia
NCT01207336 · Acute Ischaemic Stroke
NCT03865225 · Acute Ischaemic Stroke, Autonomic Dysfunction
NCT03971526 · Acute Ischaemic Stroke
Beijing Luhe Hospital,Capital Medical University
Beijing, Beijing Municipality
XuanWu Hospital, Capital Medical University
Beijing, Beijing Municipality
Liuzhou Worker's Hospital
Liuzhou, Guangxi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions